| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 11/04/2003 | US6640626 Method and system for identifying a type of gas |
| 11/04/2003 | US6640618 Method for detecting and measuring foam forming compounds in aqueous solutions |
| 11/04/2003 | CA2262739C Low background multi-well plates for fluorescence measurements of biological and biochemical samples |
| 11/04/2003 | CA2260563C Hydrogen sensor using a solid hydrogen ion conducting electrolyte |
| 11/04/2003 | CA2123570C Cocaine receptor binding ligands |
| 11/04/2003 | CA2120569C Boiler system leak detection |
| 11/04/2003 | CA2104090C Method and apparatus for testing gases, particularly breath alcohol |
| 11/04/2003 | CA2097920C Site-specific conjugation of immunoglobulins and detectable labels |
| 11/04/2003 | CA2085191C Vaccines based on modified type 1 bovine herpesviruses |
| 11/04/2003 | CA2084677C Apo ai polypeptides, antibodies, and immunoassays |
| 11/04/2003 | CA2073616C Use of hpv-16 e6 and e7-gene derived peptides for the diagnostic purpose |
| 11/04/2003 | CA2040555C Cloned glutamic acid decarboxylase |
| 11/01/2003 | CA2427092A1 Analyte concentration determination devices and methods of using the same |
| 11/01/2003 | CA2427089A1 Devices and methods for analyte concentration determination |
| 11/01/2003 | CA2427083A1 Devices and methods for analyte concentration determination |
| 11/01/2003 | CA2426589A1 Psp94 diagnostic reagents and assays |
| 11/01/2003 | CA2426282A1 Apparatuses and methods for analyte concentration determination |
| 11/01/2003 | CA2391438A1 Psp94 diagnostic reagents and assays |
| 11/01/2003 | CA2380662A1 Psp94 diagnostic reagents and assays |
| 10/30/2003 | WO2003090249A2 Sampling probe microarray read out using electrospray mass spectrometry |
| 10/30/2003 | WO2003090169A1 Method for separating a group of cells which are contained in an image sample into individual cells |
| 10/30/2003 | WO2003090128A1 Support system for judging molecule interaction according to structure |
| 10/30/2003 | WO2003089939A1 Automatic analyzing device for trace quantity of blood |
| 10/30/2003 | WO2003089938A1 Method and device for measurement of hematocrit |
| 10/30/2003 | WO2003089937A2 Quantitation of biological molecules |
| 10/30/2003 | WO2003089936A1 Aberrant-specific pathways |
| 10/30/2003 | WO2003089935A1 THE METHOD FOR MEASURING THE AMOUNT OF βiG-H3 PROTEIN AND DIAGNOSTIC KIT USING THE SAME |
| 10/30/2003 | WO2003089934A2 Method for diagnosing inflammatory diseases and infections by the determination of lasp-1/lap-1 |
| 10/30/2003 | WO2003089933A1 Uses of the carbamoyl phosphate synthesis 1 (cps 1) and the fragments thereof for the diagnosis of inflammatory diseases and sepsis |
| 10/30/2003 | WO2003089932A1 Method for detecting the presence or risk of prostate cancer by detecting products of psa or klk2 |
| 10/30/2003 | WO2003089931A1 Waveguide in porous substrates |
| 10/30/2003 | WO2003089930A1 Peripheral-type benzodiazepine receptor expression level as an index of organ damage and regeneration |
| 10/30/2003 | WO2003089928A1 Test for measurement of therapeutic drug levels |
| 10/30/2003 | WO2003089927A2 Antigens associated with haematological malignancy |
| 10/30/2003 | WO2003089925A2 Device based on partially oxidized porous silicon and method for the production thereof |
| 10/30/2003 | WO2003089924A1 Determining cancer aggressiveness |
| 10/30/2003 | WO2003089922A1 Method for detecting ligands and targets in a mixture |
| 10/30/2003 | WO2003089921A1 Methods for separation and detection of ketosteroids and other carbonyl-containing compounds |
| 10/30/2003 | WO2003089920A1 Measuring deposit forming capacity with microbalance |
| 10/30/2003 | WO2003089917A1 Biosensor cartridge and biosensor dispensing device |
| 10/30/2003 | WO2003089916A1 A sensor |
| 10/30/2003 | WO2003089915A2 Method for restoring the sensitivity, speed or stability of a gas-sensitive material |
| 10/30/2003 | WO2003089914A1 Non-boiling point indicator |
| 10/30/2003 | WO2003089913A2 Method and apparatus for assessing the integrity of a jewellery setting |
| 10/30/2003 | WO2003089909A1 Method and apparatus to detect genuine or hoax contaminants |
| 10/30/2003 | WO2003089908A1 Sample collecting device and mass spectrometry of device |
| 10/30/2003 | WO2003089906A2 Functionalized nanoparticles and methods of use |
| 10/30/2003 | WO2003089904A2 Aib1 as a prognostic marker and predictor of resistance to encocrine therapy |
| 10/30/2003 | WO2003089903A2 Compositions and methods relating to endothelial cell signaling using the protease activated receptor (par1) |
| 10/30/2003 | WO2003089902A2 Displacement assay for detection of small molecules |
| 10/30/2003 | WO2003089901A2 Methods for preparing libraries of unique tags and related screening methods |
| 10/30/2003 | WO2003089899A2 Probes for detecting tumor cells |
| 10/30/2003 | WO2003089898A2 Determining biochemical markers of progression and therapy monitoring and specification, therapeutic lead molecules, and target biochemical systems applied to stroke |
| 10/30/2003 | WO2003089896A2 Rapid assay, method and system for detecting biowarfare agents |
| 10/30/2003 | WO2003089895A2 Methods for the electrochemical detection of multiple target compounds |
| 10/30/2003 | WO2003089885A1 Flow sensor for harsh environments |
| 10/30/2003 | WO2003089672A1 Hepatitis c virus assay systems |
| 10/30/2003 | WO2003089667A1 Compositions and methods for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene |
| 10/30/2003 | WO2003089665A1 Methods for measuring protein kinase and phosphatase activity |
| 10/30/2003 | WO2003089663A2 Methods for measuring enzyme activity |
| 10/30/2003 | WO2003089662A1 Method for obtaining the binding affinities of a peptide library to a protein |
| 10/30/2003 | WO2003089660A1 Disposable sub-microliter volume sensor with enhanced sample inlet |
| 10/30/2003 | WO2003089659A1 Methods or renal cell carcinoma prognosis and treatment selection with carbonic anhydrase ix |
| 10/30/2003 | WO2003089658A1 Disposable sensor with enhanced sample port inlet |
| 10/30/2003 | WO2003089655A1 Device for retaining samples for biodetectors |
| 10/30/2003 | WO2003089652A2 Comparative phenotype analysis of cells, including testing of biologically active compounds |
| 10/30/2003 | WO2003089651A2 Assay for quantitating secreted antibodies in lymphocytes supernatant |
| 10/30/2003 | WO2003089647A1 Xanthomonas genes associated with plant pathogenicity |
| 10/30/2003 | WO2003089646A1 Novel proteins and dnas encoding the same |
| 10/30/2003 | WO2003089638A1 Nucleic acid molecule encoding a variant ddah 1 protein and uses thereof |
| 10/30/2003 | WO2003089635A1 Cytotoxicity assay |
| 10/30/2003 | WO2003089627A1 Translocation dependent complementation for drug screening |
| 10/30/2003 | WO2003089624A2 Fc receptor homolog, reagents, and uses thereof |
| 10/30/2003 | WO2003089620A2 Phospholipases, nucleic acids encoding them and methods for making and using them |
| 10/30/2003 | WO2003089616A2 Soluble mic polypeptides as markers for diagnosis, prognosis and treatment of cancer and autoimmune diseases or conditions |
| 10/30/2003 | WO2003089615A2 Antiviral inhibitions of capsid proteins |
| 10/30/2003 | WO2003089607A2 Cell wall mannoproteins and active epitopes from candida albicans and antibodies recognizing them |
| 10/30/2003 | WO2003089594A2 A device and methods for concentrating prion protein isoforms |
| 10/30/2003 | WO2003089589A2 Matrix analysis of gene expression in cells (magec) |
| 10/30/2003 | WO2003089586A2 Nucleic acid separation and detection by electrophoresis with a counter-migrating high-affinity intercalating dye |
| 10/30/2003 | WO2003089583A2 Tissue specific genes and gene clusters |
| 10/30/2003 | WO2003089580A2 Cancer models |
| 10/30/2003 | WO2003089573A2 Methods of identifying compounds that modulate a dna repair pathway and/or retroviral infectivity, the compounds, and uses thereof |
| 10/30/2003 | WO2003089571A2 Ehrlichia canis genes and vaccines |
| 10/30/2003 | WO2003089564A1 Substrate and method for measuring the electrophysiological properties of cell membranes |
| 10/30/2003 | WO2003089474A1 Dna dependent protein kinase catalytic subunit phosphorylation sites and antibodies thereto |
| 10/30/2003 | WO2003089470A1 Peptides capable of inducing attraction to the axonal growth and their use for treating neurodegenerative diseases |
| 10/30/2003 | WO2003089465A2 Crystals structure of the mouse apoptosis-inducing factor aif and applications thereof |
| 10/30/2003 | WO2003089464A1 Two green fluorescent protein fragments and their use in a method for detecting protein - protein interactions |
| 10/30/2003 | WO2003089463A1 Purified (3r)-hydroxymyristoyl-(acyl-carrier-protein) dehydratase polypeptide from pseudomonas aeruginosa |
| 10/30/2003 | WO2003089457A2 Peptide inhibitors of protein kinase c ϝ for pain management |
| 10/30/2003 | WO2003089456A2 Peptide inhibitors of protein kinase c |
| 10/30/2003 | WO2003089438A1 Labeled oxazinocarbazoles as diagnostic agents |
| 10/30/2003 | WO2003089156A1 Apparatus and method for automated parcel screening |
| 10/30/2003 | WO2003089139A1 Thermally-conductive biological assay trays |
| 10/30/2003 | WO2003089014A1 Cell growth, induction and lysis in an antibody-coated microplate for use in an elisa |
| 10/30/2003 | WO2003089003A1 Methods of treatment and diagnosis of patients with hepatitis c infection |
| 10/30/2003 | WO2003088990A1 Plasma protein-binding ligands |
| 10/30/2003 | WO2003088979A2 Oligonucleotides from sequences coding for the surface component of envelope proteins of primate t-cell leukaemia/lymphoma viruses (ptlv) and uses thereof |
| 10/30/2003 | WO2003088975A1 Inhibition of fatty acid synthase by beta-lactones and other compounds for inhibition of cellular proliferation |